Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingfei-Runzao
- Development stage
- Preclinical
- Lead developer
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Qingfei-Runzao is a traditional Chinese medicine (TCM) herbal formulation developed for the treatment of respiratory conditions. It is primarily evaluated for its clinical efficacy and safety in managing post-infectious cough (PIC) in children, particularly targeting the 'wind-dryness injuring the lung' pattern according to TCM principles. The formulation works to clear lung heat, moisten dryness, and resolve phlegm to alleviate persistent cough symptoms. It has been investigated in clinical trials conducted by institutions including the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.
- Other names
- Qingfei-Runzao granules清肺润燥颗粒
Beyond the preview
Go deeper on Qingfei-Runzao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qingfei-Runzao.